The Rotterdam criteria include irregular menses, hyperandrogenism, and ovarian volume greater than or equal to 10 mL with or without 12 or more peripheral antral follicles ranging from 29 mm in one or both ovaries [8]
Thats why so many patients tell me scents, lotions, detergents, or even seasonal changes suddenly bother them more than they used to
Pharmacoepidemiologists and endocrinologists have raised concern that the rapid increase in prescriptions for GLP-1s has, in some cases, not kept up with clinical and regulatory pathways to ensure safety and efficacy
It can start earlier than many of us expect, and it often arrives with a weird mix of symptoms that seem unrelated at first
Genetic variation is seen in every individual and therefore also makes it possible for mutations to occur
Fixed-ratio combination products containing both insulin and a GLP-1 receptor agonist are also available, including insulin glargine/lixisenatide (Soliqua) and insulin degludec/liraglutide (Xultophy)